DEA Targets Synthetic 7‑OH, Not Natural Kratom

The U.S. Drug Enforcement Administration has moved to temporarily classify the kratom‑related compound 7‑hydroxymitragynine (7‑OH) and three associated substances as Schedule I drugs, placing them alongside heroin and LSD under federal law. The action covers products containing more than 0.05 percent 7‑OH by dry weight or over 1 milligram per serving, a threshold aimed at high‑potency synthetic formulations sold in gas stations and vape shops.aapp+2

Crucially, the DEA stresses that the order targets synthesized 7‑OH products and elevated concentrations of the compound, not botanical kratom supplements that contain only trace, naturally occurring 7‑OH. Public health advocates and mainstream kratom industry groups have welcomed the move. You can read the original report via The Hill reprint on HootMD.